Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹6398 Cr.
Stock P/E
9.4
P/B
2
Current Price
₹709.2
Book Value
₹ 357.4
Face Value
10
52W High
₹1297.8
52W Low
₹ 698.2
Dividend Yield
2.12%

Sharda Cropchem Overview

Business

Sharda Cropchem Ltd. is an India-based global agrochemical company specializing in the sourcing, formulation, registration, and distribution of post-patent (generic) agrochemical products. Its core business involves identifying off-patent active ingredients, obtaining necessary registrations for their sale in various countries, and then marketing and distributing these products. The company primarily operates an asset-light model, outsourcing manufacturing while focusing on intellectual property (registrations) and global market access. Beyond agrochemicals (herbicides, fungicides, insecticides), Sharda Cropchem also has a smaller but growing non-agrochemicals segment, which includes biocides, dyes, and industrial chemicals. It makes money through the sale of these registered products across diverse geographies.

Revenue Mix

The company's revenue primarily comes from two main segments:

Agrochemicals: This is the dominant segment, encompassing herbicides, fungicides, and insecticides. Herbicides typically contribute the largest share within this segment, followed by fungicides and insecticides.

Non-Agrochemicals: This segment includes a range of industrial applications such as biocides, dyes, and other industrial chemicals, contributing a smaller but significant portion of overall revenue.

Geographically, the company has a widespread presence, with Europe, NAFTA (North America), and Latin America being significant markets, alongside other regions globally.

Industry

The agrochemicals industry is characterized by the dominance of a few large multinational players holding patents on novel chemistries, alongside a fragmented generic segment. Sharda Cropchem operates primarily in the generic/post-patent segment. Its positioning is as a global player with an extensive network of product registrations across numerous countries. While it doesn't invent new molecules, it excels in the complex and time-consuming process of obtaining regulatory approvals for off-patent products, allowing it to compete effectively against other generic players and provide alternatives to patented products. Its asset-light model allows for flexibility and lower capital expenditure compared to integrated manufacturers.

MOAT

Sharda Cropchem's key competitive advantages include:

Extensive Registration Library & Regulatory Expertise: The company has a vast portfolio of product registrations across various geographies. Obtaining these registrations is a time-consuming, expensive, and technically complex process, acting as a significant barrier to entry for new competitors. This regulatory "IP" is a core asset.

Global Distribution Network: A widespread presence and established relationships with distributors across multiple continents enable efficient market access.

Asset-Light Model: By outsourcing manufacturing, the company maintains flexibility, lower capital intensity, and can adapt quickly to market demands without significant fixed costs.

Strong Supplier Relationships: Long-standing relationships with various active ingredient manufacturers, primarily in Asia, ensure a reliable supply chain.

Growth Drivers

New Product Registrations: Continuous filing and approval of new products and active ingredients in existing and new markets are the primary growth engine.

Geographic Expansion: Penetrating new countries and strengthening market share in existing regions.

Increasing Global Food Demand: The need to feed a growing population drives demand for crop protection products to enhance yields.

Genericization of Patented Molecules: As more agrochemical patents expire, new opportunities arise for generic players like Sharda Cropchem.

Portfolio Diversification: Growth in the non-agrochemicals segment and potential expansion into new chemistries.

Risks

Regulatory Changes: Stricter environmental regulations, product bans (e.g., for specific active ingredients like glyphosate), or delays in registration processes can significantly impact revenue.

Commodity Price Volatility & Weather: Fluctuations in agricultural commodity prices affect farmer profitability and their ability to purchase agrochemicals. Adverse weather patterns can also impact demand.

Currency Fluctuations: Operating in numerous countries exposes the company to currency exchange rate risks.

Intense Competition: The generic agrochemical market is highly competitive, leading to pricing pressures.

Supply Chain Disruptions: Reliance on third-party manufacturers and global logistics means potential vulnerability to disruptions.

Dependence on Key Active Ingredients: Over-reliance on a few blockbuster molecules could pose a risk if those face regulatory challenges.

Management & Ownership

Sharda Cropchem is primarily a promoter-led company, with Mr. R.S. Bubna being the Chairman and Managing Director. The Bubna family holds a significant stake in the company, ensuring aligned long-term interests. The management team is generally viewed as experienced in the agrochemical sector, having successfully scaled the company's global operations and registration capabilities over the years. The promoter group maintains a substantial ownership stake, alongside holdings by institutional investors and the public.

Outlook

Sharda Cropchem operates in an essential industry with consistent underlying demand for crop protection. Its asset-light, registration-focused model has proven effective for global market penetration in the generic agrochemical space. The continuous addition of new product registrations and geographical expansion provide a clear pathway for future growth. However, the company faces inherent risks associated with regulatory changes, intense competition, and agricultural sector cyclicality. While its robust registration portfolio provides a defensive moat, the ability to navigate evolving global regulations and maintain competitive pricing will be crucial for sustained performance. The non-agrochemicals segment offers diversification, but agrochemicals will likely remain the primary revenue driver, tying its fortune closely to global agricultural trends and regulatory environments.

Sharda Cropchem Share Price

Live · BSE / NSE · Inception: 2004
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Sharda Cropchem Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 1312 785 777 929 1829 985 929 1289 2065 1074
Other Income -2 19 34 1 36 32 29 21 22 35
Total Income 1310 804 811 930 1864 1017 958 1310 2087 1108
Total Expenditure 1057 708 696 815 1536 770 796 1048 1578 888
Operating Profit 253 96 115 115 328 248 162 262 510 221
Interest 0 1 0 0 0 1 0 0 0 2
Depreciation 54 65 69 69 72 78 76 83 87 100
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 198 31 46 46 256 169 86 179 422 118
Provision for Tax 55 4 3 15 53 26 11 33 103 30
Profit After Tax 143 27 42 31 204 143 74 145 319 88
Adjustments -0 0 -0 0 -0 -0 -0 0 -0 0
Profit After Adjustments 143 27 42 31 204 143 74 145 319 88
Adjusted Earnings Per Share 15.9 3 4.7 3.5 22.6 15.8 8.2 16.1 35.3 9.8

Sharda Cropchem Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 1222 1399 1707 1998 2003 2396 3580 4045 3163 4320 5268 5357
Other Income 25 16 17 21 43 66 29 40 60 60 142 107
Total Income 1248 1415 1723 2018 2046 2461 3609 4085 3223 4379 5410 5463
Total Expenditure 943 1078 1351 1664 1708 1965 2884 3386 2860 3705 4209 4310
Operating Profit 305 337 372 355 338 496 725 699 363 674 1201 1155
Interest 8 9 15 20 16 16 15 20 24 21 21 2
Depreciation 35 56 70 99 137 170 245 248 267 275 325 346
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 261 272 287 235 185 309 464 431 72 378 856 805
Provision for Tax 86 81 96 59 20 80 115 89 40 74 175 177
Profit After Tax 175 190 191 176 165 229 349 342 32 304 681 626
Adjustments -0 0 -0 -0 -0 -0 -0 -0 -0 -0 -0 0
Profit After Adjustments 175 190 191 176 165 229 349 342 32 304 681 626
Adjusted Earnings Per Share 19.4 21.1 21.1 19.5 18.3 25.4 38.7 37.9 3.5 33.7 75.5 69.4

Sharda Cropchem Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 805 960 1135 1284 1403 1614 1912 2232 2237 2501 3136
Minority's Interest 0 0 0 0 0 0 0 0 0 0 1
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 181 256 317 404 435 507 610 617 672 482 236
Total Current Liabilities 542 663 1078 822 856 1140 1693 2026 1581 1986 2518
Total Liabilities 1529 1879 2530 2510 2695 3261 4216 4876 4490 4969 5890
Fixed Assets 130 210 226 372 416 544 592 668 708 750 989
Other Non-Current Assets 383 460 665 590 597 617 771 894 844 632 332
Total Current Assets 1015 1209 1639 1548 1681 2100 2853 3314 2938 3586 4570
Total Assets 1529 1879 2530 2510 2695 3261 4216 4876 4490 4969 5890

Sharda Cropchem Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 38 32 72 61 51 78 86 57 176 87 127
Cash Flow from Operating Activities 197 181 17 556 146 246 267 328 341 604 656
Cash Flow from Investing Activities -120 -104 -163 -360 -68 -282 -208 -145 -393 -510 -513
Cash Flow from Financing Activities -89 -38 132 -215 -60 43 -91 -97 -37 -68 -118
Net Cash Inflow / Outflow -12 40 -14 -19 19 8 -32 86 -89 26 24
Closing Cash & Cash Equivalent 32 72 61 51 78 86 57 176 87 127 220

Sharda Cropchem Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 19.41 21.11 21.14 19.55 18.25 25.4 38.71 37.9 3.53 33.74 75.47
CEPS(Rs) 23.3 27.34 28.9 30.56 33.45 44.3 65.91 65.41 33.15 64.19 111.45
DPS(Rs) 3 4 4 4 4 5 6 6 3 9 15
Book NAV/Share(Rs) 89.28 106.39 125.78 142.31 155.49 178.93 211.98 247.4 247.96 277.16 347.65
Core EBITDA Margin(%) 22.85 22.99 20.85 16.72 14.72 17.96 19.43 16.29 8.67 13.53 18.99
EBIT Margin(%) 22.06 20.09 17.72 12.78 10.03 13.59 13.39 11.15 2.75 8.8 15.72
Pre Tax Margin(%) 21.38 19.42 16.83 11.77 9.23 12.92 12.97 10.65 2.05 8.32 15.34
PAT Margin (%) 14.34 13.6 11.18 8.83 8.22 9.57 9.76 8.45 0.91 6.7 12.21
Cash Profit Margin (%) 17.2 17.63 15.28 13.8 15.07 16.68 16.61 14.59 8.55 12.74 18.03
ROA(%) 12.97 11.17 8.65 7 6.33 7.7 9.34 7.52 0.68 6.44 12.54
ROE(%) 24 21.57 18.22 14.58 12.26 15.19 19.81 16.5 1.43 12.85 24.16
ROCE(%) 35.95 31.81 26.71 19.72 14.95 21.11 26.39 21.55 4.29 16.87 31.1
Receivable days 160.44 168.58 167.3 155.62 164.03 163.9 137.78 152.19 173.75 138.64 142.2
Inventory Days 44.71 58.38 87.49 81.8 68.08 69.16 72.31 91.45 110.89 78.83 68.45
Payable days 142.38 171.07 174.12 167.07 173.85 166.59 144.87 163 179.1 134.48 151.79
PER(x) 12.02 23.07 18.12 19.05 5.89 11.31 15.89 12.9 90.82 16.92 11.52
Price/Book(x) 2.61 4.58 3.05 2.62 0.69 1.61 2.9 1.98 1.29 2.06 2.5
Dividend Yield(%) 1.29 0.82 1.04 1.07 3.72 1.74 0.98 1.23 0.93 1.58 1.72
EV/Net Sales(x) 1.67 3.06 2.07 1.62 0.41 1 1.51 1.05 0.89 1.14 1.45
EV/Core EBITDA(x) 6.71 12.7 9.47 9.12 2.42 4.83 7.48 6.06 7.74 7.31 6.35
Net Sales Growth(%) 15.18 14.49 21.97 17.05 0.27 19.6 49.43 13 -21.81 36.57 21.94
EBIT Growth(%) 45.97 4.25 7.6 -15.61 -21.3 62.13 47.15 -5.91 -78.7 316.21 119.26
PAT Growth(%) 42.47 8.66 0.21 -7.56 -6.61 39.18 52.38 -2.09 -90.67 854.1 123.7
EPS Growth(%) 42.41 8.74 0.17 -7.56 -6.62 39.18 52.4 -2.09 -90.68 854.67 123.69
Debt/Equity(x) 0 0 0.15 0 0 0.04 0.02 0 0 0 0
Current Ratio(x) 1.87 1.82 1.52 1.88 1.96 1.84 1.69 1.64 1.86 1.81 1.82
Quick Ratio(x) 1.58 1.39 1.03 1.45 1.52 1.38 1.16 1.08 1.23 1.32 1.37
Interest Cover(x) 32.37 30.12 19.82 12.62 12.55 20.07 31.94 22.35 3.97 18.6 41.43
Total Debt/Mcap(x) 0 0 0.05 0 0 0.03 0.01 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +22% +9% +17% +16%
Operating Profit CAGR +78% +20% +19% +15%
PAT CAGR +124% +26% +24% +15%
Share Price CAGR -13% +19% +17% +6%
ROE Average +24% +13% +15% +16%
ROCE Average +31% +17% +20% +23%

Sharda Cropchem Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 74.82 %
FII 3.11 %
DII (MF + Insurance) 9.18 %
Public (retail) 12.88 %
Others 0.01 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 74.8274.8274.8274.8274.8274.8274.8274.8274.8274.82
FII 2.142.022.523.774.695.485.264.24.63.11
DII 12.4112.8712.7610.0710.279.389.269.959.699.18
Public 10.6310.289.911.3410.2110.3210.6511.0210.8812.88
Others 0000000000
Total 100100100100100100100100100100

Sharda Cropchem Peer Comparison

Pesticides & Agrochemicals Edit Columns

Sharda Cropchem Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Sharda Cropchem Pros & Cons

Pros

  • Company has delivered good profit growth of 24% CAGR over last 5 years
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 13% over the last 3 years.
  • Debtor days have increased from 134.48 to 151.79days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp